Kymera Therapeutics Inc 's (KYMR) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Kymera Therapeutics Inc   (NASDAQ: KYMR)
 



  Kymera Therapeutics Inc Outlook

On February 22 2024 the Kymera Therapeutics Inc provided following guidance

Kymera Therapeutics Inc. reported its financial results for the fourth quarter and full year of 2023, as well as provided a business update. The company highlighted the progress of its KT-474/SAR444656 (IRAK4) Phase 2 program, which is advancing in the treatment of both Hidradenitis Suppurativa (HS) and Atopic Dermatitis (AD). Data from this program is expected to be available in the first half of 2025. This development marks a significant milestone for Kymera Therapeutics as it continues to innovate and bring potential therapeutic options to patients with these challenging conditions. The company remains committed to advancing research and development efforts to address unmet medical needs in the field of precision protein degradation.

On January 9 2024 the Kymera Therapeutics Inc provided following guidance

Kymera Therapeutics has outlined its key objectives and strategy for the year 2024, focusing on advancing its portfolio of immunology and oncology programs. One of the main goals for the company is to complete enrollment in both Phase 2 HS (Hidradenitis Suppurativa) and AD (Atopic Dermatitis) studies for its oral degrader KT-474 (SAR444656) by the fourth quarter of 2024. The company anticipates that it will obtain topline data from these studies in the first half of 2025. This progress is significant as it marks a crucial step forward in the development of Kymera Therapeutics' therapeutic options for patients in need.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.